ContactSenators

Who in Congress trades TEVA?

Teva Pharmaceutical Industries Limited

3 members of Congress have disclosed 3 TEVA transactions between October 19, 2016 – March 30, 2026. Under the STOCK Act these must be filed within 45 days of the trade.

3
transactions
3
members
1 / 2
buys / sells
$3K–$45K
disclosed value

Price and trade timing

When members traded TEVA, against its weekly closing price.

$6.41$29.5$52.5201620182020202220242026
bought sold weekly close, split-adjusted

Markers sit on the date the trade happened; it was disclosed up to 45 days later. Prices are weekly closes adjusted for splits and dividends. Shown as context for the public record — we do not calculate returns or performance for any member, and none of this is investment advice.

Who trades it most

1 trade1 buy0 sell
1 trade0 buy1 sell
1 trade0 buy1 sell

TEVA trades by year

1
16
1
17
1
26

Every disclosed TEVA trade

Newest first, through July 24, 2026. Each row links to the original filing. 1 of these were filed after the 45-day deadline.

MemberTypeAmountTradedFiling
Alan ArmstrongRBuyLate$1,001 - $15,000March 30, 2026View
Patty MurrayDSell$1,001 - $15,000June 15, 2017View
Angus S. King, Jr.ISell$1,001 - $15,000October 19, 2016View

Public STOCK Act disclosures (U.S. Senate eFD and House Clerk), shown for transparency and education — not investment advice, and not a statement of what any member currently owns. Back to the full Congress trades tracker.